Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 10, n. 2, p. 93–97, 2009. DOI: 10.7175/fe.v10i2.167. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/167. Acesso em: 28 dec. 2025.